New combo treatment shows promise for vitiligo
NCT ID NCT04237103
First seen Feb 01, 2026 · Last updated Apr 28, 2026 · Updated 11 times
Summary
This study tested whether adding the drug methotrexate to standard light therapy helps adults with active, spreading vitiligo regain skin color. Thirty-two adults took part, and researchers measured repigmentation using a special scoring system. The goal was to see if the combination works better and is safe compared to light therapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier de Pau
Pau, 64000, France
-
Centre Hospitalier de Périgueux
Périgueux, 24000, France
-
Service de Dermatologie - CHU de Toulouse - Hopital Purpan
Toulouse, 31059 Toulouse Cedex, France
-
Service de Dermatologie - Hôpital Saint-André
Bordeaux, Bordeaux, 33075, France
Conditions
Explore the condition pages connected to this study.